Sonoma Pharmaceuticals (SNOA) Operating Margin (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) operating margin from Jun 30, 2010 to Dec 31, 2025. The current Sonoma Pharmaceuticals (SNOA) operating margin is -15.63%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Sonoma Pharmaceuticals (SNOA)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -25.96% | -29.63% |
| 2024 | -36.89% | +7.12% |
| 2023 | -34.44% | -26.15% |
| 2022 | -46.63% | +151.83% |
| 2021 | -18.52% | -55.07% |
| 2020 | -41.22% | -30.56% |
| 2019 | -59.36% | -30.31% |
| 2018 | -85.17% | -15.75% |
| 2017 | -101.09% | -35.61% |
| 2016 | -156.99% | +226.47% |
| 2015 | -48.09% | +8.65% |
| 2014 | -44.26% | +102.90% |
| 2013 | -21.81% | -57.05% |
| 2012 | -50.78% | -33.98% |
| 2011 | -76.92% | N/A |
Comparison Sonoma Pharmaceuticals (SNOA) operating margin with competitors
Sonoma Pharmaceuticals (SNOA) operating margin is -15.63%.